ArticleEndocrinology2026
The EDC mixture "NeuroMix" alters neuroendocrine physiology, fatty food preference, and the central reward transcriptome.
Article in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Obesity prevalence has risen dramatically in recent decades, coincident with increasing human exposures to endocrine-disrupting chemicals (EDCs). Many EDCs act as "obesogens" by promoting adipogenesis and disrupting metabolism; however, little is known about their effects on neural circuits that regulate food reward and motivation. EDCs cause neurobiological and behavioral changes, implicating them in central energy balance regulation. In this experiment, we tested whether developmental exposure to the environmentally relevant EDC mixture NeuroMix (NMX) may have obesogenic-like effects in rats through central mechanisms. Using a dose-response approach, male and female rats were exposed perinatally to NMX (0, 0.1 ×, 1 ×, 10 × doses) and assessed for adult high-fat food and sucrose preference, thyroid hormones, and transcriptomics in reward and hypothalamic nuclei. Females exposed to the 1 × dose exhibited an increase in fatty food preference and consumption accompanied by appreciable weight gain. Males showed reduced thyroid hormone levels at the highest 10 × dose. NMX antagonized thyroid hormone receptor β in vitro, suggesting a potential molecular mechanism underlying the observed neuroendocrine effects. Transcriptomic analyses in 1 × rats identified the nucleus accumbens (NAc) as a key neural substrate in both sexes, with spliceosomal complex eigengenes in the NAc acting as correlates of high-fat food behaviors, and individual splicing factors emerging as possible neuromolecular mechanisms linking endocrine disruption to obesogenic eating. Together, this research demonstrates that environmentally relevant EDC mixtures exert sex- and dose-specific effects on food choice, thyroid hormones, and gene expression, highlighting neuromolecular reward mechanisms as potential contributors to environmentally mediated obesity risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.